Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
124.4 USD | +2.03% | -0.97% | +25.06% |
May. 07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
May. 06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.06% | 46.71B | |
+48.83% | 41.8B | |
-1.28% | 41.52B | |
-3.42% | 29.55B | |
+10.52% | 25.78B | |
-21.08% | 19.26B | |
+1.14% | 12.14B | |
-3.41% | 12.08B | |
+27.17% | 11.98B | |
+19.43% | 11.58B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : Says Interim Data From Study of COVID-19 Vaccine Showed 'Robust' Response in Children Aged Six to 11